Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2026-2032

Product Code: 1975993

Industry: Service & Software

Published: Feb 13,2026

Pages: 124

Delivery Time: 2-3 business days

Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2026-2032

Product Code: 1975993

Industry: Service & Software

Published: Feb 13,2026

Pages: 124

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Artificial Intelligence Drug R&D market size is predicted to grow from US$ 714 million in 2025 to US$ 1295 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

Artificial Intelligence Drug R&D (AI Drug Development) refers to a class of R&D methods and software/platform systems that utilize technologies such as machine learning, deep learning, generative models, and knowledge graphs to model and infer multi-omics and biomedical data throughout the entire drug development process, from target discovery to lead compounds, preclinical trials, clinical trials, and post-marketing. This aims to improve the accuracy of target selection, shorten the candidate drug discovery cycle, reduce the failure rate, and optimize trial design and patient stratification.

AI-driven drug development is transitioning from "proof of concept" to "deliverable productivity." On one hand, large pharmaceutical companies and platform companies are emphasizing interpretability, auditability, and compliance (GxP/data governance), embedding AI models into existing experimental automation, LIMS/ELN, cheminformatics, and clinical operations systems to form an "AI + experimental closed loop" (design–make–test–analyze). On the other hand, industry focus is shifting from single-point tools to end-to-end capabilities: for example, integrating target selection, molecular generation, ADMET, and clinical strategies, while enhancing model generalization capabilities through multimodal data (omics, imaging, EHR, literature, and patents), making AI more closely aligned with real-world R&D decisions.

Simultaneously, generative AI is reshaping the workflow of early-stage research and translational medicine: at the molecular and protein level, the combination of generation and screening (virtual screening + de novo design) is becoming more common; at the clinical level, real-world data and patient stratification are driving "more precise enrollment and endpoint selection" to reduce trial size or increase success rates. In terms of commercialization, the cooperation model has expanded from "software subscription" to "milestone/revenue sharing, joint R&D, and joint pipeline incubation", and places greater emphasis on quantifiable deliverables (hit rate, shortened cycle, candidate quality) and reproducible verification system.

LPI (LP Information)' newest research report, the “Artificial Intelligence Drug R&D Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Drug R&D sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug R&D sales for 2026 through 2032. With Artificial Intelligence Drug R&D sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug R&D industry.

This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug R&D landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Drug R&D portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Drug R&D market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug R&D and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug R&D.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug R&D market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Software
    Service

Segmentation by Stage:
    Target Identification & Validation
    Hit/Lead Discovery
    Clinical Development & Trial Design
    Others

Segmentation by Technology:
    Machine Learning & Deep Learning
    Generative Models
    Knowledge Graph & NLP
    Multi-omics / Multimodal Modeling

Segmentation by Application:
    Pharmaceutical Companies
    Biotechnology Companies
    Contract Research Organizations（CRO)
    Academic & Research Institutions
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Insilico Medicine
    Recursion
    BenevolentAI
    Atomwise
    Recursion Pharmaceuticals
    DeepMind（Google）
    Insitro
    Owkin
    XtalPi
    Verge Genomics
    Iktos
    Valo Health
    Standigm
    Relay Therapeutics
    Cyclica
    Isomorphic Labs
    Schrödinger
    Absci
    Genesis Therapeutics

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Artificial Intelligence Drug R&D Market Size (2021-2032)
        2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region (2021 VS 2025 VS 2032)
        2.1.3 World Current & Future Analysis for Artificial Intelligence Drug R&D by Country/Region (2021, 2025 & 2032)
    2.2 Artificial Intelligence Drug R&D Segment by Type
        2.2.1 Software
        2.2.2 Service
        2.2.3 Artificial Intelligence Drug R&D Market Size by Type
            2.2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2021 VS 2025 VS 2032)
            2.2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
    2.3 Artificial Intelligence Drug R&D Segment by Stage
        2.3.1 Target Identification & Validation
        2.3.2 Hit/Lead Discovery
        2.3.3 Clinical Development & Trial Design
        2.3.4 Others
        2.3.5 Artificial Intelligence Drug R&D Market Size by Stage
            2.3.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Stage (2021 VS 2025 VS 2032)
            2.3.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2026)
    2.4 Artificial Intelligence Drug R&D Segment by Technology
        2.4.1 Machine Learning & Deep Learning
        2.4.2 Generative Models
        2.4.3 Knowledge Graph & NLP
        2.4.4 Multi-omics / Multimodal Modeling
        2.4.5 Artificial Intelligence Drug R&D Market Size by Technology
            2.4.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Technology (2021 VS 2025 VS 2032)
            2.4.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2026)
    2.5 Artificial Intelligence Drug R&D Segment by Application
        2.5.1 Pharmaceutical Companies
        2.5.2 Biotechnology Companies
        2.5.3 Contract Research Organizations（CRO)
        2.5.4 Academic & Research Institutions
        2.5.5 Others
        2.5.6 Artificial Intelligence Drug R&D Market Size by Application
            2.5.6.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2021 VS 2025 VS 2032)
            2.5.6.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)

3 Artificial Intelligence Drug R&D Market Size by Player
    3.1 Artificial Intelligence Drug R&D Market Size Market Share by Player
        3.1.1 Global Artificial Intelligence Drug R&D Revenue by Player (2021-2026)
        3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2021-2026)
    3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Artificial Intelligence Drug R&D by Region
    4.1 Artificial Intelligence Drug R&D Market Size by Region (2021-2026)
    4.2 Global Artificial Intelligence Drug R&D Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
    4.4 APAC Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
    4.5 Europe Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
    4.6 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2021-2026)

5 Americas
    5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2021-2026)
    5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
    5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2021-2026)
    6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
    6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Artificial Intelligence Drug R&D Market Size by Country (2021-2026)
    7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
    7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2021-2026)
    8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
    8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Artificial Intelligence Drug R&D Market Forecast
    10.1 Global Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
        10.1.1 Global Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
        10.1.2 Americas Artificial Intelligence Drug R&D Forecast
        10.1.3 APAC Artificial Intelligence Drug R&D Forecast
        10.1.4 Europe Artificial Intelligence Drug R&D Forecast
        10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
    10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2027-2032)
        10.2.1 United States Market Artificial Intelligence Drug R&D Forecast
        10.2.2 Canada Market Artificial Intelligence Drug R&D Forecast
        10.2.3 Mexico Market Artificial Intelligence Drug R&D Forecast
        10.2.4 Brazil Market Artificial Intelligence Drug R&D Forecast
    10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
        10.3.1 China Artificial Intelligence Drug R&D Market Forecast
        10.3.2 Japan Market Artificial Intelligence Drug R&D Forecast
        10.3.3 Korea Market Artificial Intelligence Drug R&D Forecast
        10.3.4 Southeast Asia Market Artificial Intelligence Drug R&D Forecast
        10.3.5 India Market Artificial Intelligence Drug R&D Forecast
        10.3.6 Australia Market Artificial Intelligence Drug R&D Forecast
    10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2027-2032)
        10.4.1 Germany Market Artificial Intelligence Drug R&D Forecast
        10.4.2 France Market Artificial Intelligence Drug R&D Forecast
        10.4.3 UK Market Artificial Intelligence Drug R&D Forecast
        10.4.4 Italy Market Artificial Intelligence Drug R&D Forecast
        10.4.5 Russia Market Artificial Intelligence Drug R&D Forecast
    10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
        10.5.1 Egypt Market Artificial Intelligence Drug R&D Forecast
        10.5.2 South Africa Market Artificial Intelligence Drug R&D Forecast
        10.5.3 Israel Market Artificial Intelligence Drug R&D Forecast
        10.5.4 Turkey Market Artificial Intelligence Drug R&D Forecast
    10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2027-2032)
    10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2027-2032)
        10.7.1 GCC Countries Market Artificial Intelligence Drug R&D Forecast

11 Key Players Analysis
    11.1 Insilico Medicine
        11.1.1 Insilico Medicine Company Information
        11.1.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
        11.1.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.1.4 Insilico Medicine Main Business Overview
        11.1.5 Insilico Medicine Latest Developments
    11.2 Recursion
        11.2.1 Recursion Company Information
        11.2.2 Recursion Artificial Intelligence Drug R&D Product Offered
        11.2.3 Recursion Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.2.4 Recursion Main Business Overview
        11.2.5 Recursion Latest Developments
    11.3 BenevolentAI
        11.3.1 BenevolentAI Company Information
        11.3.2 BenevolentAI Artificial Intelligence Drug R&D Product Offered
        11.3.3 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.3.4 BenevolentAI Main Business Overview
        11.3.5 BenevolentAI Latest Developments
    11.4 Atomwise
        11.4.1 Atomwise Company Information
        11.4.2 Atomwise Artificial Intelligence Drug R&D Product Offered
        11.4.3 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.4.4 Atomwise Main Business Overview
        11.4.5 Atomwise Latest Developments
    11.5 Recursion Pharmaceuticals
        11.5.1 Recursion Pharmaceuticals Company Information
        11.5.2 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
        11.5.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.5.4 Recursion Pharmaceuticals Main Business Overview
        11.5.5 Recursion Pharmaceuticals Latest Developments
    11.6 DeepMind（Google）
        11.6.1 DeepMind（Google） Company Information
        11.6.2 DeepMind（Google） Artificial Intelligence Drug R&D Product Offered
        11.6.3 DeepMind（Google） Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.6.4 DeepMind（Google） Main Business Overview
        11.6.5 DeepMind（Google） Latest Developments
    11.7 Insitro
        11.7.1 Insitro Company Information
        11.7.2 Insitro Artificial Intelligence Drug R&D Product Offered
        11.7.3 Insitro Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.7.4 Insitro Main Business Overview
        11.7.5 Insitro Latest Developments
    11.8 Owkin
        11.8.1 Owkin Company Information
        11.8.2 Owkin Artificial Intelligence Drug R&D Product Offered
        11.8.3 Owkin Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.8.4 Owkin Main Business Overview
        11.8.5 Owkin Latest Developments
    11.9 XtalPi
        11.9.1 XtalPi Company Information
        11.9.2 XtalPi Artificial Intelligence Drug R&D Product Offered
        11.9.3 XtalPi Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.9.4 XtalPi Main Business Overview
        11.9.5 XtalPi Latest Developments
    11.10 Verge Genomics
        11.10.1 Verge Genomics Company Information
        11.10.2 Verge Genomics Artificial Intelligence Drug R&D Product Offered
        11.10.3 Verge Genomics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.10.4 Verge Genomics Main Business Overview
        11.10.5 Verge Genomics Latest Developments
    11.11 Iktos
        11.11.1 Iktos Company Information
        11.11.2 Iktos Artificial Intelligence Drug R&D Product Offered
        11.11.3 Iktos Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.11.4 Iktos Main Business Overview
        11.11.5 Iktos Latest Developments
    11.12 Valo Health
        11.12.1 Valo Health Company Information
        11.12.2 Valo Health Artificial Intelligence Drug R&D Product Offered
        11.12.3 Valo Health Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.12.4 Valo Health Main Business Overview
        11.12.5 Valo Health Latest Developments
    11.13 Standigm
        11.13.1 Standigm Company Information
        11.13.2 Standigm Artificial Intelligence Drug R&D Product Offered
        11.13.3 Standigm Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.13.4 Standigm Main Business Overview
        11.13.5 Standigm Latest Developments
    11.14 Relay Therapeutics
        11.14.1 Relay Therapeutics Company Information
        11.14.2 Relay Therapeutics Artificial Intelligence Drug R&D Product Offered
        11.14.3 Relay Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.14.4 Relay Therapeutics Main Business Overview
        11.14.5 Relay Therapeutics Latest Developments
    11.15 Cyclica
        11.15.1 Cyclica Company Information
        11.15.2 Cyclica Artificial Intelligence Drug R&D Product Offered
        11.15.3 Cyclica Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.15.4 Cyclica Main Business Overview
        11.15.5 Cyclica Latest Developments
    11.16 Isomorphic Labs
        11.16.1 Isomorphic Labs Company Information
        11.16.2 Isomorphic Labs Artificial Intelligence Drug R&D Product Offered
        11.16.3 Isomorphic Labs Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.16.4 Isomorphic Labs Main Business Overview
        11.16.5 Isomorphic Labs Latest Developments
    11.17 Schrödinger
        11.17.1 Schrödinger Company Information
        11.17.2 Schrödinger Artificial Intelligence Drug R&D Product Offered
        11.17.3 Schrödinger Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.17.4 Schrödinger Main Business Overview
        11.17.5 Schrödinger Latest Developments
    11.18 Absci
        11.18.1 Absci Company Information
        11.18.2 Absci Artificial Intelligence Drug R&D Product Offered
        11.18.3 Absci Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.18.4 Absci Main Business Overview
        11.18.5 Absci Latest Developments
    11.19 Genesis Therapeutics
        11.19.1 Genesis Therapeutics Company Information
        11.19.2 Genesis Therapeutics Artificial Intelligence Drug R&D Product Offered
        11.19.3 Genesis Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
        11.19.4 Genesis Therapeutics Main Business Overview
        11.19.5 Genesis Therapeutics Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
 Table 2. Artificial Intelligence Drug R&D Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Software
 Table 4. Major Players of Service
 Table 5. Artificial Intelligence Drug R&D Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
 Table 6. Global Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
 Table 7. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
 Table 8. Major Players of Target Identification & Validation
 Table 9. Major Players of Hit/Lead Discovery
 Table 10. Major Players of Clinical Development & Trial Design
 Table 11. Major Players of Others
 Table 12. Artificial Intelligence Drug R&D Market Size CAGR by Stage (2021 VS 2025 VS 2032) & ($ millions)
 Table 13. Global Artificial Intelligence Drug R&D Market Size by Stage (2021-2026) & ($ millions)
 Table 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2026)
 Table 15. Major Players of Machine Learning & Deep Learning
 Table 16. Major Players of Generative Models
 Table 17. Major Players of Knowledge Graph & NLP
 Table 18. Major Players of Multi-omics / Multimodal Modeling
 Table 19. Artificial Intelligence Drug R&D Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
 Table 20. Global Artificial Intelligence Drug R&D Market Size by Technology (2021-2026) & ($ millions)
 Table 21. Global Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2026)
 Table 22. Artificial Intelligence Drug R&D Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
 Table 23. Global Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
 Table 24. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
 Table 25. Global Artificial Intelligence Drug R&D Revenue by Player (2021-2026) & ($ millions)
 Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2021-2026)
 Table 27. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
 Table 28. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 29. New Products and Potential Entrants
 Table 30. Mergers & Acquisitions, Expansion
 Table 31. Global Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
 Table 32. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
 Table 33. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2021-2026) & ($ millions)
 Table 34. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2021-2026)
 Table 35. Americas Artificial Intelligence Drug R&D Market Size by Country (2021-2026) & ($ millions)
 Table 36. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2021-2026)
 Table 37. Americas Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
 Table 38. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
 Table 39. Americas Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
 Table 40. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
 Table 41. APAC Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
 Table 42. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
 Table 43. APAC Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
 Table 44. APAC Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
 Table 45. Europe Artificial Intelligence Drug R&D Market Size by Country (2021-2026) & ($ millions)
 Table 46. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2021-2026)
 Table 47. Europe Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
 Table 48. Europe Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
 Table 49. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
 Table 50. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
 Table 51. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
 Table 52. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
 Table 53. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
 Table 54. Key Industry Trends of Artificial Intelligence Drug R&D
 Table 55. Global Artificial Intelligence Drug R&D Market Size Forecast by Region (2027-2032) & ($ millions)
 Table 56. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Region (2027-2032)
 Table 57. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2027-2032) & ($ millions)
 Table 58. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2027-2032) & ($ millions)
 Table 59. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 60. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
 Table 61. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 62. Insilico Medicine Main Business
 Table 63. Insilico Medicine Latest Developments
 Table 64. Recursion Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 65. Recursion Artificial Intelligence Drug R&D Product Offered
 Table 66. Recursion Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 67. Recursion Main Business
 Table 68. Recursion Latest Developments
 Table 69. BenevolentAI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 70. BenevolentAI Artificial Intelligence Drug R&D Product Offered
 Table 71. BenevolentAI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 72. BenevolentAI Main Business
 Table 73. BenevolentAI Latest Developments
 Table 74. Atomwise Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 75. Atomwise Artificial Intelligence Drug R&D Product Offered
 Table 76. Atomwise Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 77. Atomwise Main Business
 Table 78. Atomwise Latest Developments
 Table 79. Recursion Pharmaceuticals Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 80. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
 Table 81. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 82. Recursion Pharmaceuticals Main Business
 Table 83. Recursion Pharmaceuticals Latest Developments
 Table 84. DeepMind（Google） Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 85. DeepMind（Google） Artificial Intelligence Drug R&D Product Offered
 Table 86. DeepMind（Google） Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 87. DeepMind（Google） Main Business
 Table 88. DeepMind（Google） Latest Developments
 Table 89. Insitro Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 90. Insitro Artificial Intelligence Drug R&D Product Offered
 Table 91. Insitro Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 92. Insitro Main Business
 Table 93. Insitro Latest Developments
 Table 94. Owkin Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 95. Owkin Artificial Intelligence Drug R&D Product Offered
 Table 96. Owkin Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 97. Owkin Main Business
 Table 98. Owkin Latest Developments
 Table 99. XtalPi Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 100. XtalPi Artificial Intelligence Drug R&D Product Offered
 Table 101. XtalPi Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 102. XtalPi Main Business
 Table 103. XtalPi Latest Developments
 Table 104. Verge Genomics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 105. Verge Genomics Artificial Intelligence Drug R&D Product Offered
 Table 106. Verge Genomics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 107. Verge Genomics Main Business
 Table 108. Verge Genomics Latest Developments
 Table 109. Iktos Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 110. Iktos Artificial Intelligence Drug R&D Product Offered
 Table 111. Iktos Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 112. Iktos Main Business
 Table 113. Iktos Latest Developments
 Table 114. Valo Health Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 115. Valo Health Artificial Intelligence Drug R&D Product Offered
 Table 116. Valo Health Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 117. Valo Health Main Business
 Table 118. Valo Health Latest Developments
 Table 119. Standigm Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 120. Standigm Artificial Intelligence Drug R&D Product Offered
 Table 121. Standigm Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 122. Standigm Main Business
 Table 123. Standigm Latest Developments
 Table 124. Relay Therapeutics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 125. Relay Therapeutics Artificial Intelligence Drug R&D Product Offered
 Table 126. Relay Therapeutics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 127. Relay Therapeutics Main Business
 Table 128. Relay Therapeutics Latest Developments
 Table 129. Cyclica Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 130. Cyclica Artificial Intelligence Drug R&D Product Offered
 Table 131. Cyclica Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 132. Cyclica Main Business
 Table 133. Cyclica Latest Developments
 Table 134. Isomorphic Labs Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 135. Isomorphic Labs Artificial Intelligence Drug R&D Product Offered
 Table 136. Isomorphic Labs Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 137. Isomorphic Labs Main Business
 Table 138. Isomorphic Labs Latest Developments
 Table 139. Schrödinger Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 140. Schrödinger Artificial Intelligence Drug R&D Product Offered
 Table 141. Schrödinger Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 142. Schrödinger Main Business
 Table 143. Schrödinger Latest Developments
 Table 144. Absci Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 145. Absci Artificial Intelligence Drug R&D Product Offered
 Table 146. Absci Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 147. Absci Main Business
 Table 148. Absci Latest Developments
 Table 149. Genesis Therapeutics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
 Table 150. Genesis Therapeutics Artificial Intelligence Drug R&D Product Offered
 Table 151. Genesis Therapeutics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 152. Genesis Therapeutics Main Business
 Table 153. Genesis Therapeutics Latest Developments


List of Figures
 Figure 1. Artificial Intelligence Drug R&D Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate (2021-2032) ($ millions)
 Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2025)
 Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2025
 Figure 10. Global Artificial Intelligence Drug R&D Market Size Market Share by Stage in 2025
 Figure 11. Global Artificial Intelligence Drug R&D Market Size Market Share by Technology in 2025
 Figure 12. Artificial Intelligence Drug R&D in Pharmaceutical Companies
 Figure 13. Global Artificial Intelligence Drug R&D Market: Pharmaceutical Companies (2021-2026) & ($ millions)
 Figure 14. Artificial Intelligence Drug R&D in Biotechnology Companies
 Figure 15. Global Artificial Intelligence Drug R&D Market: Biotechnology Companies (2021-2026) & ($ millions)
 Figure 16. Artificial Intelligence Drug R&D in Contract Research Organizations（CRO)
 Figure 17. Global Artificial Intelligence Drug R&D Market: Contract Research Organizations（CRO) (2021-2026) & ($ millions)
 Figure 18. Artificial Intelligence Drug R&D in Academic & Research Institutions
 Figure 19. Global Artificial Intelligence Drug R&D Market: Academic & Research Institutions (2021-2026) & ($ millions)
 Figure 20. Artificial Intelligence Drug R&D in Others
 Figure 21. Global Artificial Intelligence Drug R&D Market: Others (2021-2026) & ($ millions)
 Figure 22. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2025
 Figure 23. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2025
 Figure 24. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
 Figure 25. Americas Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
 Figure 26. APAC Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
 Figure 27. Europe Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
 Figure 28. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
 Figure 29. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2025
 Figure 30. United States Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 31. Canada Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 32. Mexico Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 33. Brazil Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 34. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2025
 Figure 35. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
 Figure 36. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
 Figure 37. China Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 38. Japan Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 39. South Korea Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 40. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 41. India Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 42. Australia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 43. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2025
 Figure 44. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
 Figure 45. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
 Figure 46. Germany Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 47. France Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 48. UK Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 49. Italy Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 50. Russia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 51. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
 Figure 52. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
 Figure 53. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
 Figure 54. Egypt Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 55. South Africa Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 56. Israel Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 57. Turkey Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 58. GCC Countries Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
 Figure 59. Americas Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 60. APAC Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 61. Europe Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 62. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 63. United States Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 64. Canada Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 65. Mexico Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 66. Brazil Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 67. China Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 68. Japan Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 69. Korea Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 70. Southeast Asia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 71. India Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 72. Australia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 73. Germany Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 74. France Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 75. UK Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 76. Italy Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 77. Russia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 78. Egypt Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 79. South Africa Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 80. Israel Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 81. Turkey Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
 Figure 82. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2027-2032)
 Figure 83. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2027-2032)
 Figure 84. GCC Countries Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)

Companies Mentioned

Insilico Medicine

Recursion

BenevolentAI

Atomwise

Recursion Pharmaceuticals

DeepMind（Google）

Insitro

Owkin

XtalPi

Verge Genomics

Iktos

Valo Health

Standigm

Relay Therapeutics

Cyclica

Isomorphic Labs

Schrödinger

Absci

Genesis Therapeutics

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff